Ontology highlight
ABSTRACT: Purpose
Despite epidemiologic and molecular differences between esophageal and stomach cancers, most published studies have included patients with either disease in a metastatic scenario. We evaluated the safety and effectiveness of chemotherapy in patients with metastatic esophageal cancer in the community setting.Patients and methods
We performed a retrospective cohort study of patients with synchronous metastatic esophageal cancer treated at a public hospital between 2008 and 2016. Patients were grouped according to a prescribed chemotherapy protocol: platinum and taxane (group A); platinum and irinotecan (group B); platinum and fluoropyrimidine (group C); and without platinum (group D).Results
Of the 1,789 patients with esophageal cancer treated, we included 397
SUBMITTER: Victor CR
PROVIDER: S-EPMC6775989 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature